申请人:Astrazeneca UK Limited
公开号:US06525060B1
公开(公告)日:2003-02-25
Triazolo[4,5-d]pyrimidine compounds, their use as medicaments, compositions containing them and processes for their preparation. The compounds of the invention have the formula (I) as follows:
wherein R, X and R1 through R3 are as defined in the specification.
Triazolo[4,5-d]嘧啶化合物,它们作为药物的用途,含有它们的组合物以及它们的制备方法。本发明的化合物具有以下式(I):
其中R、X和R1至R3如规范中所定义。